logo

For the Inventor, By the Inventor

Ness-Ziona, Israel

Asael Herman

This inventor holds 11 USPTO granted patents and 20 published patent applications. Top assignee: Emendobio Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asael Herman. Retrieved from https://idiyas.com/inventor/asael-herman-pfhrj9pc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 90.9

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal11 out of 17 
 
Emendobio Inc.
 patents

Years Active: 2023-2026

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12698513 - CRISPR compositions and methods for promoting gene editing of ribosomal protein S19 (RPS19) gene (2026-08-04),
2. 12480140 - DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE GENE (2025-11-25),
3. 12454705 - Differential knockout of an allele of a heterozygous apolipoprotein A1 (APO1A) gene (2025-10-28),
4. 12435334 - Differential knockout of an allele of a heterozygous ELANE gene-II (2025-10-07),
5. 12359196 - Differential knockout of an allele of a heterozygous fibrinogen alpha chain (FGA) gene (2025-07-15),
6. 12274758 - Guide RNA that targets a mutant human inosine monophosphate deyhydrogenase I allele (2025-04-14),
7. 12258599 - Method to inactivate a mutant allele of angene (2025-03-25),
8. 12168062 - Guide RNA that targets a mutant human guanylate cyclase 2A allele (2024-12-17),
9. 12031149 - Compositions and methods for promoting gene editing of CXCR4 gene (2024-07-09),
10. 11827879 - Differential knockout of an allele of a heterozygous bestrophin 1 gene (2023-11-28),
11. 11666641 - CRISPR nuclease (2023-06-06),

Title: Asael Herman: Innovator in Genetic Research

Introduction

Asael Herman is a prominent inventor based in Ness-Ziona, Israel. He has made significant contributions to the field of genetic research, particularly in the area of gene therapy. With a total of eight patents to his name, Herman is recognized for his innovative approaches to addressing genetic disorders.

Latest Patents

Herman's latest patents include groundbreaking methods for inactivating mutant alleles associated with severe congenital neutropenia and cyclic neutropenia. One notable patent focuses on the differential knockout of an allele of a heterozygous ELANE gene. This method involves the use of RNA molecules that target specific polymorphic sites, providing a novel approach to gene therapy. Another patent details the differential knockout of a heterozygous fibrinogen alpha chain gene, showcasing his expertise in developing RNA-based therapeutic strategies.

Career Highlights

Herman is currently affiliated with Emendobio Inc., where he continues to advance his research in genetic therapies. His work has garnered attention for its potential to improve treatment options for patients with genetic disorders. His innovative methods are paving the way for new therapeutic approaches in the field of genetics.

Collaborations

Throughout his career, Herman has collaborated with notable colleagues, including David Baram and Lior Izhar. These partnerships have contributed to the development of his patents and the advancement of genetic research.

Conclusion

Asael Herman is a distinguished inventor whose work in genetic research is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing the field of gene therapy. His contributions are essential in the ongoing quest to develop effective treatments for genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…